Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C.

Abstract

UNLABELLED:

In patients with chronic hepatitis C (CHC), cirrhosis is associated with age, gender, diabetes, alcohol abuse, and coinfection with human immunodeficiency virus (HIV) or hepatitis B virus (HBV). The effect of these factors on the outcome of cirrhosis is unknown. This study in CHC patients with cirrhosis aimed to assess the influence of these factors on decompensation, liver transplantation, and death. Consecutive patients with CHC and cirrhosis hospitalized between January 1, 2006 and December 31, 2008 were followed up until death, transplantation, or study closure in March 2013. Gender, age, Model for End-Stage Liver Disease (MELD) score, diabetes, alcohol abuse, HIV, or HBV coinfection were collected at inclusion. The complications of cirrhosis, death, and liver transplantation were recorded at inclusion and during follow-up. The association between baseline factors and liver-related outcomes at inclusion and during follow-up were tested using logistic regression and Cox's model, respectively. A total of 348 patients with CHC and cirrhosis (68% men; median age: 59 years; median MELD: 10) were included. At baseline, 40% of the patients had diabetes, 29% alcohol abuse, and 6% HIV or HBV coinfection. Baseline MELD≥10 (P<0.001), diabetes (P=0.027), and HBV coinfection (P=0.001) were independently associated with transplantation-free survival. Baseline diabetes was independently associated with ascites (P=0.05), bacterial infections (P=0.001), and encephalopathy (P<0.001) at inclusion. Baseline diabetes was independently associated with development of ascites (P=0.057), renal dysfunction (P=0.004), bacterial infections (P=0.007), and hepatocellular carcinoma (P=0.016) during the follow-up.

CONCLUSION:

In patients with CHC and cirrhosis, diabetes is an independent prognostic factor. Improving diabetes control may improve the outcome of cirrhosis.

• Authors: Laure Elkrief, Pascale Chouinard, Noelle Bendersky, David Hajage, Béatrice Larroque, Gérard Babany, Blaise Kutala, Claire Francoz, Nathalie Boyer, Richard Moreau, François Durand, Patrick Marcellin, Pierre-Emmanuel Rautou, Dominique Valla
• Journal: Hepatology (Baltimore, Md.) (Hepatology) Vol. 60 Issue 3 Pg. 823-31 (Sep 2014) ISSN: 1527-3350 [Electronic] United States
• PMID: 24841704 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2014 by the American Association for the Study of Liver Diseases.

Topics

• Aged
• Carcinoma, Hepatocellular (epidemiology, etiology, virology)
• Diabetes Complications (diagnosis, mortality, virology)
• Female
• France (epidemiology)
• Hepatitis B (complications)
• Hepatitis C, Chronic (complications, epidemiology, virology)
• Humans
• Liver Cirrhosis (diagnosis, mortality, virology)
• Liver Neoplasms (epidemiology, etiology, virology)
• Liver Transplantation
• Male
• Middle Aged
• Prognosis
• Retrospective Studies
• Risk Factors